Vmbook Online ordering

Bio Reference Laboratories Inc

I apologize, but I'm unable to provide real-time or up-to-date information about specific stocks or companies. However, I can provide some general information about Bio Reference Laboratories Inc.

Bio-Reference Laboratories, Inc. provides testing and laboratory services to the healthcare industry in the United States. The company offers a range of testing services, including esoteric testing, molecular testing, cytogenetic testing, and anatomic pathology testing.

In 2015, Bio-Reference Laboratories, Inc. was acquired by OPKO Health, Inc. OPKO Health, Inc. is a diversified healthcare company. On June 23, 2022, the company's stock (OPK) closed at $2.63 per share. The 52-week high and low are $4.45 and $2.09, respectively. The company has a market capitalization of $1.36 billion.

Bio-Reference Laboratories, Inc. was listed on the New York Stock Exchange under the ticker symbol "BRLI" before its acquisition. The company was delisted from the NYSE after its acquisition by OPKO Health, Inc.